MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced data presentations on the late-stage pipeline candidate SEP-363856, a trace amine-associated receptor 1 ...
Please provide your email address to receive an email when new articles are posted on . Latuda use was associated with statistically significant improvements on individual quality-of-life items ...
(BPT) – It is common for people to experience both periods of happiness and sadness throughout their lives, but it can be hard to determine whether prolonged versions of these emotional states ...
The US Food and Drug Administration (FDA) has approved lurasidone (Latuda, Sunovion Pharmaceuticals), already indicated for schizophrenia, to treat major depressive episodes in adults with bipolar 1 ...
If you’re looking at treatment options for bipolar I disorder or schizophrenia, you may want to learn more about Latuda (lurasidone). Latuda is a prescription drug that’s used to treat: schizophrenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results